Raiffeisen Bank International AG Has $669,000 Holdings in STAAR Surgical Company $STAA

Raiffeisen Bank International AG cut its holdings in shares of STAAR Surgical Company (NASDAQ:STAA) by 50.0% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 40,000 shares of the medical instruments supplier’s stock after selling 40,000 shares during the period. Raiffeisen Bank International AG’s holdings in STAAR Surgical were worth $669,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently modified their holdings of the business. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in shares of STAAR Surgical by 29.6% during the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 14,076 shares of the medical instruments supplier’s stock valued at $248,000 after purchasing an additional 3,217 shares in the last quarter. XTX Topco Ltd acquired a new stake in STAAR Surgical during the 1st quarter worth approximately $561,000. US Bancorp DE lifted its stake in STAAR Surgical by 1,693.0% in the first quarter. US Bancorp DE now owns 2,044 shares of the medical instruments supplier’s stock valued at $36,000 after buying an additional 1,930 shares in the last quarter. Jupiter Asset Management Ltd. lifted its stake in STAAR Surgical by 50.1% in the first quarter. Jupiter Asset Management Ltd. now owns 566,079 shares of the medical instruments supplier’s stock valued at $9,980,000 after buying an additional 188,830 shares in the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. increased its position in shares of STAAR Surgical by 40.3% during the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 91,800 shares of the medical instruments supplier’s stock worth $1,618,000 after acquiring an additional 26,364 shares in the last quarter. 96.70% of the stock is currently owned by institutional investors.

STAAR Surgical Price Performance

Shares of NASDAQ:STAA opened at $25.67 on Wednesday. The company’s 50-day moving average price is $26.59 and its two-hundred day moving average price is $22.73. STAAR Surgical Company has a one year low of $13.50 and a one year high of $30.81. The stock has a market capitalization of $1.28 billion, a PE ratio of -13.30 and a beta of 0.92.

Analyst Upgrades and Downgrades

Several research firms recently commented on STAA. Weiss Ratings reaffirmed a “sell (d)” rating on shares of STAAR Surgical in a research report on Wednesday, October 8th. Piper Sandler reissued a “neutral” rating on shares of STAAR Surgical in a research note on Monday, October 27th. Stifel Nicolaus set a $28.00 price target on STAAR Surgical and gave the company a “hold” rating in a report on Thursday, August 7th. Finally, Canaccord Genuity Group reiterated a “hold” rating and set a $28.00 price objective on shares of STAAR Surgical in a report on Tuesday, October 21st. Ten investment analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Reduce” and a consensus target price of $20.67.

STAAR Surgical Profile

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.